Evidence map›Paper›PMID 40408562›Full record

ArticleAnalytical chemistry2025

FLIMPA: A Versatile Software for Fluorescence Lifetime Imaging Microscopy Phasor Analysis.

Sofia Kapsiani, Nino F Läubli, Edward N Ward, Mona Shehata, Clemens F Kaminski, Gabriele S Kaminski Schierle

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Discovery of TDP-43 aggregation inhibitorsbioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sofia KapsianiDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, U.K.ORCID 0000-0001-6234-8246
Nino F LäubliDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, U.K.ORCID 0000-0003-2894-2385
Edward N WardDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, U.K.
Mona ShehataAnalytical Sciences, Bioassay, Biosafety and Impurities, BioPharmaceutical Development, AstraZeneca, Cambridge CB2 0AA, U.K.
Clemens F KaminskiDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, U.K.ORCID 0000-0002-5194-0962
Gabriele S Kaminski SchierleDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, U.K.ORCID 0000-0002-1843-2202

Funding

Wellcome Trust
6 · The paper itself

Abstract

Fluorescence lifetime imaging microscopy (FLIM) is an advanced microscopy technique capable of providing a deeper understanding of the molecular environment of a fluorophore. While FLIM data were traditionally analyzed through the exponential fitting of the fluorophores' emission decays, the use of phasor plots is increasingly becoming the preferred standard. This is due to their ability to visualize the distribution of fluorescent lifetimes within a sample, offering insights into molecular interactions in the sample without the need for modeling assumptions regarding the exponential decay behavior of the fluorophores. However, so far, most researchers have had to rely on commercial phasor plot software packages which are closed-source and only work with proprietary data formats. In this paper, we introduce FLIMPA, an accessible, open-source, stand-alone software for phasor plot analysis that provides many of the features found in commercial software, and more. FLIMPA is fully developed in Python and offers advanced tools for data analysis and visualization. It enhances FLIM data comparison by integrating phasor points from multiple trials and experimental conditions into a single plot, while also providing the possibility to explore detailed, localized insights within individual samples interactively. We apply FLIMPA to introduce a novel cell-based assay for the quantification of microtubule depolymerization, measured through fluorescence lifetime changes of SiR-tubulin, in response to various concentrations of Nocodazole, a microtubule depolymerizing drug relevant to anticancer treatment.

Indexed as

SoftwareFluorescent DyesHumansMicroscopy, FluorescenceMicrotubulesTubulinFluorescent DyesTubulin

Identifiers

PMID40408562
PMCPMC12163867

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.